Stock News
LLAP Investors: Lead the Way in the Terran Orbital Corporation Securities Fraud Lawsuit with The Schall Law Firm
LLAP Investors: Lead the Way in the Terran Orbital Corporation Securities Fraud Lawsuit with The Schall Law Firm Description: LOS ANGELES , Oct. 2, 2024 /PRNewswire/ — The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Terran Orbital Corporation (“Terran Orbital” or “the Company”) (NYSE: LLAP)…
Lesaka Acquires Adumo, Solidifying its Role as the Top Independent Fintech in Southern Africa
Lesaka Technologies Acquires Adumo RF Expanding Horizons: Lesaka Technologies’ Latest Acquisition On October 2, 2024, Lesaka Technologies, Inc. announced the successful completion of its acquisition of Adumo RF (Pty) Ltd. This strategic move was finalized through the issuance of 17,279,803 shares of Lesaka’s common stock and a cash payment of ZAR 232.2 million ($13.4 million),…
IMC Germany Crushes Q3 Expectations with 50% Growth: A Playful and Relatable Update!
Welcome to the Cannabis Success Story! A Remarkable 50% Increase in Revenue for IM Cannabis Corp. October 2, 2024 Hey there, fellow cannabis enthusiasts! Have you heard the exciting news? IM Cannabis Corp. is on a winning streak with their German subsidiary, Adjupharm GmbH, reporting a phenomenal 50% increase in revenue for the third quarter…
Alterity Therapeutics Shines at International Congress of Parkinson’s Disease and Movement Disorders: A Recap of Multiple Data Presentations
ATH434 Shows Promise as a Disease-Modifying Therapy for MSA ATH434-202 Phase 2 Interim Data Demonstrate Stabilization of Clinical Symptoms MELBOURNE, Australia and SAN FRANCISCO, Oct. 02, 2024 (GLOBE NEWSWIRE) — Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE), a biotechnology company dedicated to developing disease modifying treatments for neurodegenerative diseases, today announced that multiple oral and poster…
CME Group Breaks Records with All-Time Quarterly and September ADV Driven by Growth Across All Asset Classes
Record Quarterly and September ADV for CME Group in Q3 2024 CME Group Breaks Records with 28.3 Million Contracts in Q3 CME Group, the world’s leading derivatives marketplace, has reported record-breaking numbers for the third quarter of 2024. With an average daily volume (ADV) of 28.3 million contracts, the company saw a hefty 27% increase…
Breaking Boundaries: Lilly Unveils $4.5 Billion ‘Medicine Foundry’ to Revolutionize Drug Production and Advance Clinical Trials
Eli Lilly and Company Announces $4.5 Billion Investment in New Research and Manufacturing Facility INDIANAPOLIS, Oct. 2, 2024 /PRNewswire/ — Eli Lilly and Company (NYSE: LLY) today announced a $4.5 billion investment to create the Lilly Medicine Foundry, a new center for advanced manufacturing and drug development. This unique facility will give Lilly the ability…
Unlocking the Power of Emotional Connection: A Heartfelt and Insightful Look at the Impact of Human Connection
Investigation of Progyny, Inc. by Levi & Korsinsky Recently, Levi & Korsinsky announced that they have started an investigation into Progyny, Inc. regarding potential violations of federal securities laws. This news has caused a stir in the investment community, with many investors concerned about the implications of this investigation. The Disclosure Progyny, Inc. revealed in…
Unlocking the Power of Accesswire: A Comprehensive Guide to Maximizing Your Online Presence
Levi & Korsinsky Investigates Edwards Lifesciences for Possible Securities Violations New York, NY / ACCESSWIRE / October 2, 2024 Investigation Commenced on Edwards Lifesciences Corporation Levi & Korsinsky, a leading law firm in securities litigation, has announced that it is investigating Edwards Lifesciences Corporation (“Edwards Lifesciences”) (NYSE:EW) for possible violations of federal securities laws. The…